Development
Healthcare Realty Trust Incorporated
HR
$14.92
$0.040.27%
NYSE
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | 44.27% | 85.48% | 136.30% | 106.07% | 74.40% |
Total Other Revenue | 34.31% | 68.98% | 87.20% | 82.88% | 84.11% |
Total Revenue | 44.01% | 85.04% | 134.79% | 105.41% | 74.64% |
Cost of Revenue | 44.69% | 74.94% | 109.70% | 85.05% | 60.62% |
Gross Profit | 43.60% | 91.51% | 152.06% | 119.37% | 84.19% |
SG&A Expenses | 10.75% | 23.28% | 59.13% | 54.36% | 54.41% |
Depreciation & Amortization | 61.28% | 130.17% | 234.45% | 182.34% | 123.51% |
Other Operating Expenses | -- | -27.01% | -36.18% | 52.78% | 100.00% |
Total Operating Expenses | 51.40% | 98.35% | 161.01% | 125.99% | 88.45% |
Operating Income | -35.95% | -25.66% | -21.10% | -12.81% | -2.58% |
Income Before Tax | -793.20% | -380.67% | -364.32% | -205.59% | -38.95% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -793.20% | -380.67% | -364.32% | -205.59% | -38.95% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 1,773.53% | 1,124.36% | -- | -- | -- |
Net Income | -780.39% | -378.31% | -361.19% | -204.23% | -38.65% |
EBIT | -35.95% | -25.66% | -21.10% | -12.81% | -2.58% |
EBITDA | 48.46% | 104.59% | 175.24% | 136.04% | 93.64% |
EPS Basic | -343.75% | -233.58% | -204.61% | -136.50% | -32.90% |
Normalized Basic EPS | -238.00% | -7,456.82% | -394.21% | -275.71% | -180.38% |
EPS Diluted | -347.16% | -235.95% | -207.30% | -137.73% | -32.76% |
Normalized Diluted EPS | -240.43% | -6,447.06% | -393.54% | -275.11% | -179.80% |
Average Basic Shares Outstanding | 50.36% | 96.18% | 149.34% | 113.20% | 76.71% |
Average Diluted Shares Outstanding | 49.86% | 95.31% | 149.79% | 113.65% | 77.20% |
Dividend Per Share | 19.35% | 19.35% | 20.21% | -15.18% | -14.66% |
Payout Ratio | -1.24% | -1.81% | -1.89% | -2.90% | 1.64% |